EPA and/or DHA? A test question on the principles and opportunities in utilizing the therapeutic potential of omega-3 fatty acids1
Main Author: | Wolf-Hagen Schunck |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520309287 |
Similar Items
-
Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition
by: Barbara Troesch, et al.
Published: (2020-08-01) -
Omega-3 Long-Chain Polyunsaturated Fatty Acids, EPA and DHA: Bridging the Gap between Supply and Demand
by: Douglas R Tocher, et al.
Published: (2019-01-01) -
Producing Omega-3 Polyunsaturated Fatty Acids: A Review of Sustainable Sources and Future Trends for the EPA and DHA Market
by: Laura Oliver, et al.
Published: (2020-12-01) -
Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA and DHA
by: Simon eDyall
Published: (2015-04-01) -
Omega-3 Fatty Acids DHA and EPA Reduce Bortezomib Resistance in Multiple Myeloma Cells by Promoting Glutathione Degradation
by: Jing Chen, et al.
Published: (2021-09-01)